Biocon receives three US FDA observations on its Telangana plant ...Middle East

Biotechnology major Biocon on Thursday said the US health regulator has issued three observations after inspecting its Telangana-based manufacturing plant. The US Food and Drug Administration (USFDA) concluded a pre-approval inspection for Site 3 located at Hyderabad on July 20, Biocon Ltd said in a regulatory filing. "Three observations were cited at the end of the inspection, which we will be addressing within the stipulated time," it added. The company stands committed to quality, safety and efficacy of its products, the Bengaluru-based company said.

Hence then, the article about biocon receives three us fda observations on its telangana plant was published today ( Thursday 21/07/2022 - 05:40 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biocon receives three US FDA observations on its Telangana plant )

Also on site :

• Hikvision earns ISO/IEC 29147 and ISO/IEC 30111 certification for vulnerability management
• Körber to acquire majority stake in Stellium to expand supply chain consulting capabilities
• iQIYI Reaches New Heights: 880 Invention Patents Filed in 2025, Over Half Driven by AI Innovation, Further Building Up Its AIGC Leadership